Dolphin Medical Services Limited saw significant leadership changes as Managing Director and CEO G V Mohan Prasad resigned from his post with immediate effect. Two other directors, Lakshmi Sudha Madala and Dwarakanath Madala, also stepped down during the same period.

The Board of Directors accepted these resignations in a meeting held on September 12, 2026. The session commenced at 7:00 pm and concluded at 7:20 pm IST. The board placed on record its appreciation for the contributions made by all three individuals during their respective tenures.

Resignation Details

The departures were formalized through separate resignation letters dated September 12, 2026. All three outgoing officials cited professional commitments or personal reasons without disclosing further material causes for their exit.

G V Mohan Prasad confirmed in his resignation letter that there were no other material reasons for his departure aside from those mentioned. He requested the board to complete necessary statutory formalities with the Registrar of Companies and stock exchanges.

Lakshmi Sudha Madala and Dwarakanath Madala provided similar confirmations regarding their resignations. Dwarakanath Madala specifically noted his professional commitments as the driver for his exit. None of the resigning directors hold directorships in other listed entities, according to the disclosure annexures.

The company disclosed these developments pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information was filed with the Bombay Stock Exchange under scrip code 526504.

Dolphin Medical Services Limited has obtained regulatory approval to extend the deadline for holding its Annual General Meeting (AGM) for FY26. The Registrar of Companies (ROC) Hyderabad granted a two-month extension, allowing the company to convene the meeting on or before November 30, 2026.

Regulatory Approval Details

The ROC Hyderabad issued the approval letter dated August 31, 2026, under Section 96(1) of the Companies Act, 2013. The original statutory deadline for the AGM was September 30, 2026. The company applied for this extension via Service Request Number (SRN) AC5243512 on August 11, 2026.

The order, signed by Assistant Registrar Satya Singh, notes that the extension is granted considering the circumstances preventing the timely holding of the meeting. The regulator advised the company to ensure careful compliance with the Companies Act provisions in the future.

Next Steps

Dolphin Medical will intimitate the specific date of the AGM in due course. The meeting will cover the financial year ended March 31, 2026. No financial results or operational metrics were disclosed in this filing.